Colorectal cancer: Improving screening in a rural clinic. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not include a full text component.

Expression of GHRH-R in primary and metastatic mammary carcinomas. This is an ASCO Meeting Abstract from the 2014 Breast Cancer Symposium. This abstract does not include a full text component.

(HealthDay)—A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ultrasonography (US), according to research ...

Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that the lesions are ...

Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be ...

Receiving your mammogram results can be an emotional experience. Whether the news is positive or requires further investigation, it’s important to understand what these results mean for your breast ...

A multicenter American College of Radiology Imaging Network trial has determined that breast lesions categorized as BI-RADS 3 or probably benign have low malignancy rates, suggesting that follow-up ...

Leesburg, VA, July 15, 2021--According to ARRS' American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) ...

OAK BROOK, Ill. – Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound ...

Response-Guided Neoadjuvant Chemo Beneficial in Breast CA A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ...